au.\*:("VAITKEVICIUS V")
Results 1 to 25 of 31
Selection :
ERADICATION AND PALLIATION OF AQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS WITH CHEMOTHERAPY, RADIOTHERAPY, AND SURGICAL THERAPYSTEIGER Z; FRANKLIN R; WILSON RF et al.1981; J. THERAC. CARDIOVASC. SURG.; ISSN 0022-5223; USA; DA. 1981; VOL. 82; NO 5; PP. 713-719; BIBL. 14 REF.Article
COMPLETE ERADICATION OF SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS WITH COMBINED CHEMOTHERAPY AND RADIOTHERAPYSTEIGER Z; FRANKLIN R; WILSON RF et al.1981; AM. SURG.; ISSN 0003-1348; USA; DA. 1981; VOL. 47; NO 3; PP. 95-98; BIBL. 7 REF.Article
CARCINOMA OF PROSTATE METASTATIC TO BREASTDRELICHMAN A; AMER M; PONTES E et al.1980; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1980; VOL. 16; NO 3; PP. 250-255; BIBL. 35 REF.Article
Foamy gland pattern of pancreatic ductal adenocarcinoma : A deceptively benign-appearing variantADSAY, V; LOGANI, S; SARKAR, F et al.The American journal of surgical pathology. 2000, Vol 24, Num 4, pp 493-504, issn 0147-5185Article
Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinomaYIWEI LI; BHUIYAN, M; VAITKEVICIUS, V. K et al.Pancreas. 1999, Vol 18, Num 1, pp 104-110, issn 0885-3177Article
Combined therapy for cancer of the anal canal : a preliminary reportNIGRO, N. D; VAITKEVICIUS, V. K; CONSIDINE, B. JR et al.Diseases of the colon & rectum. 1993, Vol 36, Num 7, pp 709-711, issn 0012-3706Article
Dynamic management of squamous cell cancer of the anal canalNIGRO, N. D; VAITKEVICIUS, V. K; CONSIDINE, B. JR et al.Investigational new drugs. 1989, Vol 7, Num 1, pp 83-89, issn 0167-6997Article
Computerized bone scan: a potentially useful technique to measure response in prostatic carcinoma = Scintigraphie osseuse automatisée. Une technique potentiellement utile pour apprécier la réponse thérapeutique des cancers de la prostateDRELICHMAN, A; DECKER, D. A; MUHYI AL-SARRAF et al.Cancer. 1984, Vol 53, Num 5, pp 1061-1065, issn 0008-543XArticle
Developments in the systemic therapy of pancreatic cancerEL-RAYES, B. F; SHIELDS, A. F; VAITKEVICIUS, V et al.Cancer investigation. 2003, Vol 21, Num 1, pp 73-86, issn 0735-7907, 14 p.Article
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignanciesVAISHAMPAYAN, U. N; BEN-JOSEF, E; PHILIP, P. A et al.International journal of radiation oncology, biology, physics. 2002, Vol 53, Num 3, pp 675-679, issn 0360-3016Article
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: A phase II studyAHMED, S; VAITKEVICIUS, V. K; ZALUPSKI, M. M et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 420-424, issn 0277-3732Article
A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer two dose schedulesMARTINO, S; SAMAL, B. A; SINGHAKOWINTA, A et al.Journal of cancer research and clinical oncology. 1984, Vol 108, Num 3, pp 354-356, issn 0171-5216Article
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaZALUPSKI, M. M; SHIELDS, A. F; PHILIP, P. A et al.Investigational new drugs. 1998, Vol 16, Num 1, pp 93-96, issn 0167-6997Article
Relationship of family cancer history to the expression of P53, P21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinomaDERGHAM, S. T; DUGAN, M. C; ARLAUSKAS, P et al.International journal of pancreatology. 1997, Vol 21, Num 3, pp 225-234, issn 0169-4197Article
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : An intergroup studyAL-SARRAF, M; MARTZ, K; HERSKOVIC, A et al.Journal of clinical oncology. 1997, Vol 15, Num 1, pp 277-284, issn 0732-183XArticle
Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirusJOSHI, U. S; DERGHAM, S. T; CHEN, Y. Q et al.Pancreas. 1998, Vol 16, Num 2, pp 107-113, issn 0885-3177Article
Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumorsSHRIDHAR, R; SHRIDHAR, V; WANG, S et al.Cancer research (Baltimore). 1996, Vol 56, Num 19, pp 4347-4350, issn 0008-5472Article
Cancer of the anal canal: model for preoperative adjuvant combined modality therapyLEICHMAN, L; NIGRO, N; BAKER, L et al.The American journal of medicine. 1985, Vol 78, Num 2, pp 211-215, issn 0002-9343Article
An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice : Potential application for preclinical studiesMOHAMMAD, R. M; AL-KATIB, A; PETTIT, G. R et al.Clinical cancer research. 1998, Vol 4, Num 4, pp 887-894, issn 1078-0432Article
Mutations in the arginine-rich protein gene (ARP) in pancreatic cancerSHRIDHAR, V; RIVARD, S; VAITKEVICIUS, V. K et al.Oncogene (Basingstoke). 1997, Vol 14, Num 18, pp 2213-2216, issn 0950-9232Article
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinomaDERGHAM, S. T; DUGAN, M. C; KUCWAY, R et al.International journal of pancreatology. 1997, Vol 21, Num 2, pp 127-143, issn 0169-4197Conference Paper
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaPHILIP, Philip A; ZALUPSKI, Mark M; VAITKEVICIUS, V. K et al.Cancer. 2001, Vol 92, Num 3, pp 569-577, issn 0008-543XArticle
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human Pancreatic cancerZHANQUAN HE; EVELHOCH, J. L; MOHAMMAD, R. M et al.Pancreas. 2000, Vol 21, Num 1, pp 69-76, issn 0885-3177Conference Paper
The clinical significance of p21WAF1/CIP-1 and p53 expression in pancreatic adenocarcinomaDERGHAM, S. T; DUGAN, M. C; JOSHI, U. S et al.Cancer. 1997, Vol 80, Num 3, pp 372-381, issn 0008-543XArticle
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinomaMOHAMMAD, R. M; YIWEI LI; MOHAMED, A. N et al.Pancreas. 1999, Vol 19, Num 4, pp 353-361, issn 0885-3177Conference Paper
